Ledger.Open graph →
SEC Form D · filed April 24, 2014

LORUS THERAPEUTICS INC

Offering
$28.8M
Sold
$28.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
TORONTO, Ontario, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jim A. Wright · TORONTO, Ontario, CanadaDirectorBrian A. Underdown · TORONTO, Ontario, CanadaDirectorBrad A. Thompson · TORONTO, Ontario, CanadaDirectorGregory A. Chow · TORONTO, Ontario, CanadaExecDenis A. Burger · TORONTO, Ontario, CanadaDirectorWilliam G. Rice · TORONTO, Ontario, CanadaExec · DirectorMark A. Vincent · TORONTO, Ontario, CanadaDirectorAvanish A. Vellanki · TORONTO, Ontario, CanadaExecWarren A. Whitehead · TORONTO, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

LORUS THERAPEUTICS INC — SEC Form D filing (2014) | Ledger